Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75


The expression of aldehyde dehydrogenase family in breast cancer.

Qiu Y, Pu T, Li L, Cheng F, Lu C, Sun L, Teng X, Ye F, Bu H.

J Breast Cancer. 2014 Mar;17(1):54-60. doi: 10.4048/jbc.2014.17.1.54. Epub 2014 Mar 28.


ALDH(+)/CD44(+) cells in breast cancer are associated with worse prognosis and poor clinical outcome.

Qiu Y, Pu T, Guo P, Wei B, Zhang Z, Zhang H, Zhong X, Zheng H, Chen L, Bu H, Ye F.

Exp Mol Pathol. 2016 Feb;100(1):145-50. doi: 10.1016/j.yexmp.2015.11.032. Epub 2015 Dec 11.


Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis.

Liu S, Liu C, Min X, Ji Y, Wang N, Liu D, Cai J, Li K.

PLoS One. 2013 Nov 25;8(11):e81050. doi: 10.1371/journal.pone.0081050. eCollection 2013.


Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures.

Saw YT, Yang J, Ng SK, Liu S, Singh S, Singh M, Welch WR, Tsuda H, Fong WP, Thompson D, Vasiliou V, Berkowitz RS, Ng SW.

BMC Cancer. 2012 Aug 1;12:329.


High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.

Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL.

J Cell Mol Med. 2009 Aug;13(8B):2236-52. doi: 10.1111/j.1582-4934.2008.00455.x. Epub 2008 Aug 4.


Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.

Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee PW.

Stem Cells. 2011 Jan;29(1):32-45. doi: 10.1002/stem.563.


High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.

Kim RJ, Park JR, Roh KJ, Choi AR, Kim SR, Kim PH, Yu JH, Lee JW, Ahn SH, Gong G, Hwang JW, Kang KS, Kong G, Sheen YY, Nam JS.

Cancer Lett. 2013 Jun 1;333(1):18-31. doi: 10.1016/j.canlet.2012.11.026. Epub 2012 Nov 19.


High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.

Cortes-Dericks L, Galetta D, Spaggiari L, Schmid RA, Karoubi G.

Eur J Cardiothorac Surg. 2012 Jun;41(6):e173-81. doi: 10.1093/ejcts/ezs170. Epub 2012 Apr 23.


Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.

Croker AK, Allan AL.

Breast Cancer Res Treat. 2012 May;133(1):75-87. doi: 10.1007/s10549-011-1692-y. Epub 2011 Aug 5.


Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.

Cheng S, Douglas-Jones A, Yang X, Mansel RE, Jiang WG.

Cancer Genomics Proteomics. 2010 Mar-Apr;7(2):67-73.


Presence of intratumoral stem cells in breast cancer patients with or without BRCA germline mutations.

Singer CF, Zabkova P, Rappaport C, Muhr D, Pfeiler G, Gschwantler-Kaulich D, Fink-Retter A, Staudigl C, Walter I, Hudelist G, Spiess AC, Kubista E.

Curr Cancer Drug Targets. 2012 Jan;12(1):44-50.


Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.

Wei L, Liu TT, Wang HH, Hong HM, Yu AL, Feng HP, Chang WW.

Breast Cancer Res. 2011 Oct 24;13(5):R101. doi: 10.1186/bcr3042.


Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.

Currie MJ, Beardsley BE, Harris GC, Gunningham SP, Dachs GU, Dijkstra B, Morrin HR, Wells JE, Robinson BA.

Hum Pathol. 2013 Mar;44(3):402-11. doi: 10.1016/j.humpath.2012.06.004. Epub 2012 Oct 1.


Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.

Morimoto K, Kim SJ, Tanei T, Shimazu K, Tanji Y, Taguchi T, Tamaki Y, Terada N, Noguchi S.

Cancer Sci. 2009 Jun;100(6):1062-8. doi: 10.1111/j.1349-7006.2009.01151.x. Epub 2009 Mar 9.


Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.

Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q, Li C, Wang LP, Roby KF, Orsulic S, Connolly DC, Zhang Y, Montone K, Bützow R, Coukos G, Zhang L.

PLoS One. 2010 Apr 21;5(4):e10277. doi: 10.1371/journal.pone.0010277.


Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers.

Jiang WG, Watkins G, Lane J, Cunnick GH, Douglas-Jones A, Mokbel K, Mansel RE.

Clin Cancer Res. 2003 Dec 15;9(17):6432-40.


Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.

Dahl E, En-Nia A, Wiesmann F, Krings R, Djudjaj S, Breuer E, Fuchs T, Wild PJ, Hartmann A, Dunn SE, Mertens PR.

BMC Cancer. 2009 Nov 24;9:410. doi: 10.1186/1471-2407-9-410.


Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma.

Zou B, Sun S, Qi X, Ji P.

Mol Med Rep. 2012 Apr;5(4):1116-20. doi: 10.3892/mmr.2012.781. Epub 2012 Feb 3.


Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules.

Isfoss BL, Holmqvist B, Jernström H, Alm P, Olsson H.

BMC Clin Pathol. 2013 Nov 4;13(1):28. doi: 10.1186/1472-6890-13-28.


Stem cell markers aldehyde dehydrogenase type 1 and nestin expressions in renal cell cancer.

Ozbek E, Calik G, Otunctemur A, Aliskan T, Cakir S, Dursun M, Somay A.

Arch Ital Urol Androl. 2012 Mar;84(1):7-11.

Items per page

Supplemental Content

Write to the Help Desk